October 17, 2017

MeiraGTx Presents Preclinical Data on its Ocular Gene Therapy Studies for the Treatment of Leber’s Congenital Amaurosis, Achromatopsia and X-Linked Retinitis Pigmentosa at ESGCT 2017 Congress in Berlin

Results support MeiraGTx’s clinical development strategies in all three inherited retinopathies  MeiraGTx has clinical trials in all three inherited retinopathies  New York, NY, Berlin, Oct 17, 2017 (PR NEWSWIRE) – MeiraGTx, a New York and London based gene therapy company,... View Article

May 31st, 2017

MeiraGTx Announces Opening of European Technology Hub

Leiden, NL.  MeiraGTx, a New York, London, and Leiden based gene therapy company, announced today the opening of their operations in Leiden, the Netherlands.  MeiraGTx has established a European technology development hub at the Leiden Bio Science Park (https://leidenbiosciencepark.nl/) to... View Article

Contact Us

430 East 29th Street, 10th Floor
New York, NY 10016



follow me on Twitter

follow me on facebook